Antiphospholipid antibodies, antiphospholipid syndrome and infections

Autoimmunity Reviews

Volumn 7, Issue 4, 2008, Pages 272-277

  Sène, Damien ^a   Piette, Jean Charles ^a   Cacoub, Patrice ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; HCV; HIV; Infections

Indexed keywords

ANTI BETA 2 GLYCOPROTEIN ANTIBODY; ANTIBODY; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CHICKENPOX; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; HEMATOLOGIC DISEASE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIASIS; LEPROSY; LEPTOSPIROSIS; MALARIA; MICROVASCULATURE; MORTALITY; MULTIPLE ORGAN FAILURE; MYCOBACTERIOSIS; PARASITOSIS; PREVALENCE; Q FEVER; REVIEW; RICKETTSIOSIS; SYPHILIS; THROMBOSIS; VIRUS INFECTION;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BACTERIAL INFECTIONS; BETA 2-GLYCOPROTEIN I; HUMANS; INFECTION; PARASITIC DISEASES; THROMBOSIS; VIRUS DISEASES;

EID: 39649089396     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.10.001     Document Type: Review

References (40)

1. Hughes G.R., Harris N.N., and Gharavi A.E. The anticardiolipin syndrome. J Rheumatol 13 (1986) 486-489
2. Asherson R.A., Khamashta M.A., Ordi-Ros J., Derksen R.H., Machin S.J., Barquinero J., et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68 (1989) 366-374
3. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534
4. Hunt J.E., McNeil H.P., Morgan G.J., Crameri R.M., and Krilis S.A. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1 (1992) 75-81
5. Shoenfeld Y., Blank M., Cervera R., Font J., Raschi E., and Meroni P.L. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65 (2006) 2-6
6. Harel M., Aron-Maor A., Sherer Y., Blank M., and Shoenfeld Y. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 210 (2005) 743-747
7. Munoz-Rodriguez F.J., Tassies D., Font J., Reverter J.C., Cervera R., Sanchez-Tapias J.M., et al. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 30 (1999) 770-773
8. Cacoub P., Musset L., Amoura Z., Guilani P., Chabre H., Lunel F., et al. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. J Rheumatol 24 (1997) 2139-2144
9. Guglielmone H., Vitozzi S., Elbarcha O., and Fernandez E.. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 60 (2001) 500-504
10. Sthoeger Z.M., Fogel M., Smirov A., Ergas D., Lurie Y., Bass D.D., et al. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection. Ann Rheum Dis 59 (2000) 483-486
11. Ordi-Ros J., Villarreal J., Monegal F., Sauleda S., Esteban I., and Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 7 (2000) 241-244
12. Leroy V., Arvieux J., Jacob M.C., Maynard-Muet M., Baud M., and Zarski J.P. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 101 (1998) 468-474
13. Biron C., Andreani H., Blanc P., Ramos J., Ducos J., Guigue N., et al. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med 131 (1998) 243-250
14. Mangia A., Margaglione M., Cascavilla I., Gentile R., Cappucci G., Facciorusso D., et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 94 (1999) 2983-2987
15. Zachou K., Liaskos C., Christodoulou D.K., Kardasi M., Papadamou G., Gatselis N., et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Investig 33 (2003) 161-168
16. Dalekos G.N., Kistis K.G., Boumba D.S., Voulgari P., Zervou E.K., Drosos A.A., et al. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 12 (2000) 67-74
17. Ramos-Casals M., Cervera R., Lagrutta M., Medina F., Garcia-Carrasco M., de la Red G., et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38 (2004) 1009-1016
18. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46 (2002) 1019-1027
19. Giordano P., Galli M., Del Vecchio G.C., Altomare M., Norbis F., Ruggeri L., et al. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia. Br J Haematol 102 (1998) 903-906
20. Malnick S.D., Abend Y., Evron E., and Sthoeger Z.M. HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy. J Clin Gastroenterol 24 (1997) 40-42
21. Johnstone F.D., Kilpatrick D.C., and Burns S.M. Anticardiolipin antibodies and pregnancy outcome in women with human immunodeficiency virus infection. Obstet Gynecol 80 (1992) 92-96
22. Coll Daroca J., Gutierrez-Cebollada J., Yazbeck H., Berges A., Rubies-Prat J., et al. Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection?. Infection 20 (1992) 140-142
23. Abuaf N., Laperche S., Rajoely B., Carsique R., Deschamps A., Rouquette A.M., et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 77 (1997) 856-861
24. Petrovas C., Vlachoyiannopoulos P.G., Kordossis T., and Moutsopoulos H.M. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 13 (1999) 347-355
25. Loizou S., Singh S., Wypkema E., and Asherson R.A. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 62 (2003) 1106-1111
26. Palomo I., Alarcon M., Sepulveda C., Pereira J., Espinola R., and Pierangeli S. Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J Clin Lab Anal 17 (2003) 209-215
27. Hassoun A., Al-Kadhimi Z., and Cervia J. HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS 18 (2004) 333-340
28. Elefsiniotis I.S., Diamantis I.D., Dourakis S.P., Kafiri G., Pantazis K., and Mavrogiannis C. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis. Eur J Gastroenterol Hepatol 15 (2003) 721-726
29. Cervera R., Asherson R.A., Acevedo M.L., Gomez-Puerta J.A., Espinosa G., De La Red G., et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63 (2004) 1312-1317
30. Labarca J.A., Rabaggliati R.M., Radrigan F.J., Rojas P.P., Perez C.M., Ferres M.V., et al. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 24 (1997) 197-200
31. van Hal S., Senanayake S., and Hardiman R. Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J Clin Virol 32 (2005) 245-247
32. Gratacos E., Torres P.J., Vidal J., Font J., Antolin E., Cararach V., et al. Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection. Prenat Diagn 15 (1995) 1109-1113
33. Faghiri Z., Wilson W.A., Taheri F., Barton E.N., Morgan O.S., and Gharavi A.E. Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus 8 (1999) 210-214
34. Hojnik M., Gilburd B., Ziporen L., Blank M., Tomer Y., Scheinberg M.A., et al. Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 3 (1994) 515-521
35. Arvieux J., Renaudineau Y., Mane I., Perraut R., Krilis S.A., and Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost 87 (2002) 599-605
36. de Larranaga G.F., Forastiero R.R., Carreras L.O., and Alonso B.S. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 96 (1999) 19-25
37. Santiago M., Martinelli R., Ko A., Reis E.A., Fontes R.D., Nascimento E.G., et al. Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 19 (2001) 425-430
38. Vidal M., Corbin V., Chanet V., Ruivard M., Gourdon F., Laurichesse H., et al. [Infections associated to severe thrombotic events and antiphospholipid antibodies]. Med Mal Infect 35 (2005) 552-555
39. Asherson R.A. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun Rev 6 (2006) 64-67
40. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355-377